These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2034870

  • 1. [The immunogenicity of the hepatitis B vaccine in drug addicts with human immunodeficiency virus infection].
    Menicagli V, Barbanera M, Menicagli S.
    Recenti Prog Med; 1991 Feb; 82(2):69-71. PubMed ID: 2034870
    [Abstract] [Full Text] [Related]

  • 2. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C.
    J Infect Dis; 2005 May 01; 191(9):1435-41. PubMed ID: 15809901
    [Abstract] [Full Text] [Related]

  • 3. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.
    Mannucci PM, Zanetti AR, Gringeri A, Tanzi E, Morfini M, Messori A, Tirindelli MC, de Biasi R, Ciavarella N, Colombo M.
    Arch Intern Med; 1989 Jun 01; 149(6):1333-7. PubMed ID: 2525013
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Mach T.
    Przegl Epidemiol; 2007 Jun 01; 61(2):339-47. PubMed ID: 17956052
    [Abstract] [Full Text] [Related]

  • 5. Loss of hepatitis B antibody in human immunodeficiency virus-positive hemophilia patients.
    Drake JH, Parmley RT, Britton HA.
    Pediatr Infect Dis J; 1987 Nov 01; 6(11):1051-4. PubMed ID: 2962061
    [Abstract] [Full Text] [Related]

  • 6. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA, Vuola JM, Valle M, von Reyn CF.
    Vaccine; 2004 Nov 25; 23(2):205-9. PubMed ID: 15531038
    [Abstract] [Full Text] [Related]

  • 7. Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.
    Fernandez-Cruz E, Fernandez AM, Gutierrez C, Garcia-Montes M, de la Morena MT, Rodriguez-Villanueva J, Longo N, Zabay JM.
    Clin Exp Immunol; 1988 May 25; 72(2):190-5. PubMed ID: 3261660
    [Abstract] [Full Text] [Related]

  • 8. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
    Thaithumyanon P, Punnahitananda S, Praisuwanna P, Thisyakorn U, Ruxrungtham K.
    J Med Assoc Thai; 2002 Mar 25; 85(3):277-82. PubMed ID: 12117014
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B vaccine: extending immunogenicity.
    Horton RC.
    Br J Hosp Med; 1990 Jun 25; 43(6):409. PubMed ID: 2364233
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of minimal doses of an American hepatitis B vaccine in neonates.
    Scaravelli C, Bianchi E, Biraghi V, Mariani G, Calligari GC, Lucchesi P, De Leo G.
    Clin Ther; 1985 Jun 25; 7(6):680-3. PubMed ID: 2934134
    [Abstract] [Full Text] [Related]

  • 11. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct 25; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 12. Persistence of hepatitis B vaccine immunity in hemodialysis patients.
    Ramezani A, Velayati AA, Eslamifar A, Banifazl M, Ahmadi F, Maziar S, Razeghi E, Kalantar E, Amirkhani A, Aghakhani A.
    Ther Apher Dial; 2008 Apr 25; 12(2):143-6. PubMed ID: 18387163
    [Abstract] [Full Text] [Related]

  • 13. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients.
    Novick DM, Joseph H, Croxson TS, Salsitz EA, Wang G, Richman BL, Poretsky L, Keefe JB, Whimbey E.
    Arch Intern Med; 1990 Jan 25; 150(1):97-9. PubMed ID: 2297301
    [Abstract] [Full Text] [Related]

  • 14. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A, Zarei S, Shokri F.
    Vaccine; 2008 Jan 10; 26(2):269-76. PubMed ID: 18037544
    [Abstract] [Full Text] [Related]

  • 15. Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic.
    Simani OE, Leroux-Roels G, François G, Burnett RJ, Meheus A, Mphahlele MJ.
    Vaccine; 2009 Jan 01; 27(1):146-51. PubMed ID: 18940220
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S, Yoshida K, Sato T, Shimada H, Deguchi T.
    Hepatogastroenterology; 1990 Dec 01; 37 Suppl 2():140-4. PubMed ID: 2150664
    [Abstract] [Full Text] [Related]

  • 17. [The immune response and its dynamic changes of anti-HBs in 98 juveniles vaccinated with native hepatitis B vaccine].
    Zhang MT.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1990 Nov 01; 24(6):341-3. PubMed ID: 2099271
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of antinuclear antibodies, anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies in heroin abusers.
    Nikolova M, Liubomirova M, Iliev A, Krasteva R, Andreev E, Radenkova J, Minkova V, Djerassi R, Kiperova B, Vlahov ID.
    Isr Med Assoc J; 2002 Nov 01; 4(11 Suppl):908-10. PubMed ID: 12455177
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
    Ungulkraiwit P, Jongjirawisan Y, Atamasirikul K, Sungkanuparph S.
    Southeast Asian J Trop Med Public Health; 2007 Jul 01; 38(4):680-5. PubMed ID: 17883006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.